As of 2025-09-17, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -1.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 172.60 mil USD. EDIT's TTM EBITDA according to its financial statements is -156.26 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 15.8x | 15.6x |
| Forward P/E multiples | 13.7x - 17.7x | 15.5x |
| Fair Price | (23.14) - (26.62) | (26.11) |
| Upside | -917.7% - -1040.5% | -1022.7% |
| Date | EV/EBITDA |
| 2025-09-16 | -1.10 |
| 2025-09-15 | -1.01 |
| 2025-09-12 | -1.02 |
| 2025-09-11 | -1.04 |
| 2025-09-10 | -0.95 |
| 2025-09-09 | -1.06 |
| 2025-09-08 | -1.08 |
| 2025-09-05 | -1.06 |
| 2025-09-04 | -0.93 |
| 2025-09-03 | -0.91 |
| 2025-09-02 | -0.90 |
| 2025-08-29 | -0.95 |
| 2025-08-28 | -1.00 |
| 2025-08-27 | -1.01 |
| 2025-08-26 | -1.05 |
| 2025-08-25 | -1.04 |
| 2025-08-22 | -1.09 |
| 2025-08-21 | -1.05 |
| 2025-08-20 | -1.01 |
| 2025-08-19 | -0.99 |
| 2025-08-18 | -1.05 |
| 2025-08-15 | -1.22 |
| 2025-08-14 | -1.18 |
| 2025-08-13 | -1.25 |
| 2025-08-12 | -0.79 |
| 2025-08-11 | -0.74 |
| 2025-08-08 | -0.75 |
| 2025-08-07 | -0.91 |
| 2025-08-06 | -0.93 |
| 2025-08-05 | -0.97 |
| 2025-08-04 | -0.95 |
| 2025-08-01 | -0.88 |
| 2025-07-31 | -0.92 |
| 2025-07-30 | -0.93 |
| 2025-07-29 | -0.97 |
| 2025-07-28 | -1.18 |
| 2025-07-25 | -1.29 |
| 2025-07-24 | -1.35 |
| 2025-07-23 | -1.47 |
| 2025-07-22 | -1.41 |
| 2025-07-21 | -1.29 |
| 2025-07-18 | -1.06 |
| 2025-07-17 | -1.05 |
| 2025-07-16 | -1.11 |
| 2025-07-15 | -1.06 |
| 2025-07-14 | -1.12 |
| 2025-07-11 | -1.13 |
| 2025-07-10 | -1.24 |
| 2025-07-09 | -1.25 |
| 2025-07-08 | -1.12 |